Financial Performance - Net loss attributable to common stockholders was $0.8 million, or $0.01 per diluted share[24], compared to a $3.1 million loss, or $0.05 per diluted share, in the prior year period[24] - Funds from operations (FFO) attributable to common stockholders and noncontrolling interest was $14.3 million, or $0.20 per share and unit[24], compared to $13.9 million, or $0.20 per share and unit, in the prior year period[24] - Adjusted funds from operations (AFFO) attributable to common stockholders and noncontrolling interest was $16.6 million, or $0.23 per share and unit[24], compared to $15.7 million, or $0.22 per share and unit, in the prior year period[24] - The company reaffirms its full year 2025 AFFO per share and unit guidance of $0.89 to $0.93[24] Portfolio and Investment Activities - Gross investment in real estate totaled $1.5 billion[9, 30] with 193 buildings across 35 states[9] - The company completed acquisitions of medical properties for an aggregate purchase price of $38.1 million with annualized base rent of $3.6 million in April 2025[24] - The company sold a medical facility in Chipley, Florida for gross proceeds of $1.4 million, resulting in a gain of $0.2 million[24] - Total annualized base rent (ABR) for the portfolio is $117.5 million[30] with a weighted average cap rate of 8.0%[9, 30] and leased occupancy of 94.5%[9, 30] Debt and Capitalization - The company's leverage was 47.2% as of June 30, 2025[24], and Net Debt / Annualized Adjusted EBITDAre was 6.8x for the second quarter of 2025[24] - As of August 4, 2025, the company's borrowing capacity under the credit facility was $177 million[24]

Financial Data and Key Metrics Changes - The second quarter adjusted funds from operations (AFFO) were $0.77 per share, and funds available for distribution (FAD) were $0.74 per share, reflecting strong revenue and EBITDA growth primarily driven by acquisitions and active portfolio management [6][10][11] - Revenue for the second quarter was $283 million, up from $253 million in the previous year, attributed to new investments, operator restructurings, and annual escalators [10][11] - Net income for the second quarter was $140 million or $0.46 per share, compared to $117 million or $0.45 per share for the previous year [10] - NAREIT FFO for the second quarter was $213 million or $0.70 per share, compared to $189 million or $0.72 per share for the previous year [11] - The company raised and narrowed its 2025 AFFO guidance to a range of $3.40 to $3.70 per share [6][14] Business Line Data and Key Metrics Changes - The senior housing portfolio has grown to 396 facilities, representing 38% of the total operating facility portfolio [8] - The trailing twelve-month operator EBITDAR coverage for the core portfolio remained flat at 1.51 times, indicating operators' ability to cover rent [22] - Genesis filed for Chapter 11 bankruptcy, but Omega expects to receive full monthly contractual rent during this period [8][24] Market Data and Key Metrics Changes - The company has over $2 billion in liquidity with low leverage, positioning it well for growth in both senior housing and skilled nursing portfolios [9] - The UK market continues to be a significant driver of new investment activity, accounting for approximately $392 million or 65% of total new investments [29][30] Company Strategy and Development Direction - The company is focused on active portfolio management, seeking to divest underperforming facilities and source operators better suited for certain facilities [77] - Omega is exploring various investment structures to create incremental value and align interests with operators [77][94] - The company is optimistic about the long-term growth potential in both skilled nursing and senior housing sectors, supported by demographic trends [33][77] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to weather potential challenges from Medicaid funding cuts due to strong fundamentals and lobbying efforts [33][35] - The company anticipates continued improvements in coverage metrics based on preliminary results from April and May [66] Other Important Information - The company has entered into derivative instruments to mitigate foreign currency fluctuations on income from UK investments [18] - The One Big Beautiful Bill Act (OBBBA) signed into law is seen as a positive development for the industry, particularly for skilled nursing [32] Q&A Session Summary Question: Details on the investment pipeline and yields - The investment pipeline remains strong with yields around 10% across various asset classes [38] Question: Expected rent trajectory for Maplewood - Maplewood's rent is expected to increase as occupancy grows and operational efficiencies are realized [41][43] Question: Changes in balance sheet strategy - The company opted for debt issuance instead of equity to fund upcoming bond maturities, maintaining a leverage-neutral position [46][47] Question: Confidence in Genesis assets during bankruptcy - The master lease structure prevents Genesis from selectively rejecting assets, ensuring stability in rent payments [84][85] Question: Dividend increase considerations - The board is considering a dividend increase once the payout ratio is in the 80% range [82] Question: Labor market conditions - Operators are experiencing normal inflationary wage increases, with CNAs being the most challenging positions to fill [71][72]

Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q2 2025 was $0.77 per share, an increase from $0.72 per share in Q2 2024, reflecting strong revenue and EBITDA growth [5][9] - Revenue for Q2 2025 was $283 million, up from $253 million in Q2 2024, primarily due to new investments and annual escalators [8] - Net income for Q2 2025 was $140 million or $0.46 per share, compared to $117 million or $0.45 per share in Q2 2024 [8] - NAREIT FFO for Q2 2025 was $213 million or $0.70 per share, compared to $189 million or $0.72 per share in Q2 2024 [9] Business Line Data and Key Metrics Changes - The senior housing portfolio now comprises 396 facilities, representing 38% of the total operating facility portfolio [6] - The company completed $527 million in new investments during Q2 2025, with a focus on real estate acquisitions [26] - The occupancy level for the Maplewood portfolio was 95% as of July 2025, with expectations for rent payments to increase in the coming quarters [25] Market Data and Key Metrics Changes - The trailing twelve-month operator EBITDAR coverage for the core portfolio remained flat at 1.51 times, indicating stable operator performance [20] - Genesis filed for Chapter 11 bankruptcy, with Omega committed to supporting the process while expecting full monthly contractual rent during this period [21][22] Company Strategy and Development Direction - The company raised and narrowed its 2025 AFFO guidance to a range of $3.40 to $3.70 per share, reflecting strong earnings and strategic financing decisions [5][13] - Omega is focused on active portfolio management and is exploring various investment structures to enhance shareholder value [77][98] - The company continues to see ample opportunities in the UK market, with a significant portion of new investments coming from existing operators [28][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to weather potential challenges from Medicaid funding changes due to strong fundamentals and demographic trends [32] - The company anticipates continued growth in EBITDAR coverage based on preliminary results from April and May 2025 [65] - Management highlighted the importance of legislative support for the long-term care industry, which is expected to positively impact operations [31] Other Important Information - The company has $2 billion in liquidity and a low leverage ratio, positioning it well for future growth [7][13] - Omega's balance sheet metrics are strong, with a fixed charge coverage ratio of 5.4 times and net funded debt to annualized adjusted normalized EBITDA at 3.67 times [13] Q&A Session Summary Question: Details on the investment pipeline and yields - The investment pipeline remains strong, with yields around 10% across various asset classes, including US senior housing and skilled nursing facilities [37][38] Question: Expected rent trajectory for Maplewood - Maplewood's recent rent payments were $6.1 million, with expectations for further increases as occupancy and rates improve [41][42] Question: Changes in balance sheet strategy - The company opted for debt issuance instead of equity to fund upcoming bond maturities, maintaining a leverage-neutral position [47][48] Question: Confidence in Genesis assets during bankruptcy - The master lease structure prevents Genesis from selectively rejecting assets, ensuring the stability of Omega's portfolio during the reorganization [86][87] Question: Dividend increase considerations - The board is considering a dividend increase once the payout ratio is in the 80% range, with visibility into potential changes in the next few quarters [82][83]

Core Insights - Healthcare Realty Trust reported a GAAP net loss of $157.9 million, or $0.45 per share, for Q2 2025, compared to a loss of $143.8 million, or $0.39 per share, in Q2 2024 [3][5] - The company achieved NAREIT FFO of $120.4 million, or $0.34 per share, and Normalized FFO of $143.7 million, or $0.41 per share, showing slight improvements year-over-year [3][5] - The company executed 341 new and renewal leases totaling 1.5 million square feet during the quarter, with a 5.1% growth in cash NOI and a 90% occupancy rate [4][5] Financial Performance - The company’s total revenues for Q2 2025 were $297.5 million, slightly down from $298.9 million in Q1 2025 [29] - Property operating expenses were $109.9 million, while general and administrative expenses increased to $23.5 million [29] - The company reported a total asset value of $10.2 billion as of Q2 2025, down from $10.5 billion in Q1 2025 [26] Leasing Activity - The weighted average lease term for new leases was 5.3 years, with an average annual escalator of 3.2% [6] - Health system leasing constituted approximately 33% of the signed lease volume in the quarter [6] - Significant new leases included a 24,000 square foot lease with CLS Health in Houston and a 23,000 square foot lease with UC Irvine Health in California [6] Disposition and Debt Management - The company completed asset sales totaling $182.4 million through nine transactions in Q2 2025, contributing to a year-to-date total of $210.5 million at a blended cap rate of 6.2% [7][8] - The run-rate Net Debt to Adjusted EBITDA ratio improved to 6.0x, with expectations to decrease to between 5.4x and 5.7x by year-end [7][8] - A $1.5 billion revolving credit facility was extended to mature in July 2030, with additional extension options on outstanding term loans [8] Strategic Initiatives - The company announced a series of leadership changes, including the appointment of Peter Scott as President and CEO, and initiated a platform restructuring to enhance operational performance [10][12] - A Strategic Plan was published to outline actions aimed at maximizing shareholder value and improving operational performance [9] - The Board approved a common stock dividend of $0.24 per share, representing a 23% reduction from the previous level [13][14] Guidance - The company increased its Normalized FFO per share guidance to a range of $1.57 to $1.61 and adjusted Same Store Cash NOI growth guidance to 3.25% - 4.00% [15] - The updated guidance reflects the company's outlook on rental rates, occupancy levels, and operating expenses [15]

Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q1 2025 were $0.75 per share, and funds available for distribution (FAD) were $0.71 per share, reflecting revenue and EBITDA growth, with leverage reduced to 3.7x debt to EBITDA [5][12] - Revenue for Q1 2025 was $277 million, up from $243 million in Q1 2024, primarily due to new investments and operator restructurings [9] - Net income for Q1 2025 was $112 million or $0.33 per share, compared to $69 million or $0.27 per share in Q1 2024 [10] Business Line Data and Key Metrics Changes - The percentage of private pay and other revenue increased from 8% ten years ago to 39% today, with expectations for continued growth in this area [8] - Maplewood paid $15.6 million in rent in Q1 2025, an increase of $3.3 million from Q4 2024, and occupancy for the Maplewood portfolio reached 94% as of April 2025 [20] Market Data and Key Metrics Changes - The UK market accounted for approximately 93% of total new investments in Q1 2025, with a strong pipeline of opportunities [23][25] - The trailing twelve-month operator EBITDAR coverage for the core portfolio increased to 1.51x as of December 31, 2024, indicating improved performance [18] Company Strategy and Development Direction - The company is focused on disciplined and sustainable investment decisions while expanding its operator base in both the US and UK markets [18][24] - Omega is looking to opportunistically fund investments with equity, positioning itself for outsized adjusted FFO growth [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability of Genesis to continue paying rent despite recent liquidity issues, citing strong coverage metrics [6][33] - The company remains optimistic about the overall coverage and fundamentals improving in the healthcare sector, despite potential Medicaid cuts [28][29] Other Important Information - The company raised and narrowed its full-year adjusted FFO guidance to a range between $2.95 to $3.01 per share [14] - The company has a strong balance sheet with $368 million in cash and full borrowing capacity of its $1.45 billion credit facility [12] Q&A Session Summary Question: Details on Genesis and its rent payment issues - Management indicated that Genesis's recent rent payment issues were a one-time event related to their ABL lender tightening availability, and they expect continued payments moving forward [31][33] Question: Insights on the UK portfolio acquisition - The UK acquisition was facilitated by a strong platform and relationships with multiple operators, allowing for a quick and efficient transaction [39][41] Question: Impact of immigration on labor availability - No significant impact on labor availability or wage pressures has been observed at this time [45] Question: Genesis's operating fundamentals - Coverage metrics for Genesis have improved, with the portfolio consistently above 1.5 times [47] Question: Provider tax and Medicaid changes - The greatest risk to traditional Medicaid is provider taxes, which may see slight reductions, but the overall impact remains uncertain [76][78] Question: Disposition strategy and market opportunities - The company executed dispositions to redeploy capital effectively, taking advantage of attractive offers for non-core assets [82][84]

Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q1 2025 were $0.75 per share, and funds available for distribution (FAD) were $0.71 per share, reflecting revenue and EBITDA growth [6][11] - Revenue for Q1 2025 was $277 million, up from $243 million in Q1 2024, primarily due to new investments and operator restructurings [10] - Net income for Q1 2025 was $112 million, or $0.33 per share, compared to $69 million, or $0.27 per share, in Q1 2024 [10][11] - NAREIT FFO for Q1 was $184 million, or $0.62 per share, compared to $153 million, or $0.60 per share, in Q1 2024 [11] Business Line Data and Key Metrics Changes - The percentage of private pay and other revenue increased from 8% ten years ago to 39% today, with expectations for continued growth [9] - Maplewood's occupancy for its core portfolio reached 94% as of April 2025, with rent payments improving significantly [20] Market Data and Key Metrics Changes - The trailing twelve-month operator EBITDAR coverage for the core portfolio increased to 1.51x as of December 31, 2024, compared to 1.50x for the previous period [18] - Omega's investment activity in Q1 2025 included over $423 million in new real estate investments and $34 million in CapEx investments [22] Company Strategy and Development Direction - The company raised and narrowed its full-year adjusted FFO guidance to a range between $2.95 to $3.01 per share, assuming no change in revenue related to operators [14] - Omega is focusing on disciplined and sustainable investment decisions while serving a complex resident population across various asset types and markets [19] - The company continues to prioritize capital allocation towards accretive owned real estate deals that grow its balance sheet [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability of Genesis to continue paying rent, despite recent liquidity issues [7][35] - The company remains optimistic about the overall coverage and fundamentals improving, with no significant changes expected in the lending environment [29][63] - Management is closely monitoring potential Medicaid reforms and their implications for the business [29][81] Other Important Information - The company completed a $344 million investment for a portfolio of 45 care homes across the UK and Jersey, with an initial cash yield of 10% [24] - The federal judge ruled in favor of the industry regarding staffing mandates, which is expected to save the federal government $22 billion over ten years [28] Q&A Session Summary Question: Details on Genesis not paying rent and interest in March - Management indicated that Genesis has a weak balance sheet, and the shortfall was a one-time issue related to their ABL lender [34][36] Question: More details on the UK portfolio acquisition - The acquisition involved six operators and was completed quickly due to the company's strong platform in the UK [41][42] Question: Impact of immigration on labor availability and wage pressures - Management has not seen any significant impact from immigration on labor availability or wage pressures at this time [46] Question: Genesis operating fundamentals - Coverage metrics for Genesis have improved, with the portfolio consistently above 1.5 times [47] Question: Cap rates for yields on first quarter dispositions - Management indicated that the dispositions were both opportunistic and part of a cleanup of non-core assets [85]

Core Points - Healthcare Realty Trust reported a net loss attributable to common stockholders of $(44.9) million, or $(0.13) per diluted common share for Q1 2025 [1][19] - The company declared a quarterly dividend of $0.31 per share, payable on May 23, 2025 [3] - The company reaffirmed its earnings per share guidance for 2025, with a range of $(0.28) to $(0.20) [4] Leasing - Portfolio leasing activity in Q1 2025 totaled 1,450,000 square feet across 377 leases, including 1,002,000 square feet of renewals and 448,000 square feet of new and expansion leases [5] - The company signed new leases totaling 370,000 square feet in the first quarter [5] Same Store Metrics - Same store occupancy increased to 89.3% as of the end of Q1 2025, up from 89.2% in Q4 2024 [5] - Tenant retention improved to 84.8% in Q1 2025, compared to 81.6% in Q4 2024 [5] Balance Sheet - Total assets decreased to $10.5 billion in Q1 2025 from $10.7 billion in Q4 2024 [14][15] - Total liabilities remained relatively stable at $5.3 billion in Q1 2025, compared to $5.3 billion in Q4 2024 [15] Leadership - Peter A. Scott was appointed as President & CEO effective April 15, 2025, succeeding Connie Moore, who served as Interim President and CEO [5] Dividend - The company will pay a cash dividend of $0.31 per share on May 23, 2025, to Class A common stockholders of record on May 12, 2025 [3] Guidance - The company provided guidance for 2025, with expected earnings per share ranging from $(0.28) to $(0.20) and NAREIT FFO per share between $1.44 and $1.48 [4]